Importer of Controlled Substances Application: VHG Labs DBA LGC Standards, 82401-82403 [2023-25989]
Download as PDF
<![CDATA[
82401
Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices
Drug
code
Controlled substance
Morphine .......................................................................................................................................................................................
Thebaine .......................................................................................................................................................................................
Levo-alphacetylmethadol ..............................................................................................................................................................
Oxymorphone ...............................................................................................................................................................................
Thiafentanil ...................................................................................................................................................................................
Alfentanil .......................................................................................................................................................................................
Sufentanil ......................................................................................................................................................................................
Carfentanil ....................................................................................................................................................................................
Fentanyl ........................................................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
analytical testing. In reference to drug
codes 7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetics. No other activities for
these drug codes are authorized for this
registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–25947 Filed 11–22–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1294]
Importer of Controlled Substances
Application: VHG Labs DBA LGC
Standards
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
VHG Labs DBA LGC
Standards has applied to be registered
as an importer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 26, 2023. Such
persons may also file a written request
for a hearing on the application on or
before December 26, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
SUMMARY:
In
accordance with 21 CFR 1301.34(a), this
is notice that on November 6, 2023,
VHG Labs DBA LGC Standards, 3
Perimeter Road, Manchester, New
Hampshire 03103–3341, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
ddrumheller on DSK120RN23PROD with NOTICES1
Drug code
Amineptine (7-[(10,11-dihydro-5Hdibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) ........................................................
Mesocarb (N-phenyl-N′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) ..............................................
3-Fluoro-N-methylcathinone (3-FMC) .....................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) 1238 I N .....................................................................................................................
Pentedrone (a-methylaminovalerophenone) ..........................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) .......................................................................................................................................
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) 1478 I N ..............................................................................
N,N-Dimethylamphetamine ....................................................................................................................................................
Fenethylline ............................................................................................................................................................................
4-Methylaminorex (cis isomer) ...............................................................................................................................................
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine).
Mecloqualone .........................................................................................................................................................................
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ....................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ..............................................................................................................................
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ....
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................................
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ........................................................................
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ................................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .......................
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ...............
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) .......................................
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ..
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ...........................................
21:46 Nov 22, 2023
Jkt 262001
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
Controlled substance
VerDate Sep<11>2014
9300
9333
9648
9652
9729
9737
9740
9743
9801
Schedule
E:\FR\FM\24NON1.SGM
24NON1
Schedule
1219
1227
1233
1238
1246
1249
1478
1480
1503
1590
1595
I
I
I
I
I
I
I
I
I
I
I
2572
7010
7011
7012
7019
7021
7023
7024
7025
7031
7034
7041
7042
7049
I
I
I
I
I
I
I
I
I
I
I
I
I
I
82402
Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-(4cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ...............................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ..............................................................................................................
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .........................................................................................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .....................................................................................
N-ethylhexedrone 7246 I N ....................................................................................................................................................
Alpha-ethyltryptamine .............................................................................................................................................................
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine) ..............................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ........................................................................
2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ........................................................................................................
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) ....................................................................................................
3,4,5-Trimethoxyamphetamine ...............................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ....................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ....................................................................................................................................
2,5-Dimethoxy-4-ethylamphetamine .......................................................................................................................................
3,4-Methylenedioxyamphetamine ...........................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ..............................................................................................................................
Alpha-methyltryptamine ..........................................................................................................................................................
Diethyltryptamine ....................................................................................................................................................................
Dimethyltryptamine .................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ....................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ...........................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ...........................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ......................................................................................................................................
N-Benzylpiperazine ................................................................................................................................................................
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) .........................................................................................................
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) .............................................................................................................
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) .................................................................................................................
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ...........................................................................................................
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ............................................................................................................
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) .....................................................................................................
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ............................................................................................
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .................................................................
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ............................................................
alpha-pyrrolidinopentiophenone (a-PVP) ...............................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) .................................................................................................................................
Ethylone ..................................................................................................................................................................................
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ...........................................................................................................
Difenoxin .................................................................................................................................................................................
Nicomorphine .........................................................................................................................................................................
Drotebanol ..............................................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ......................................................................
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .........................................................................
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ..........................................................................................................
Acetylmethadol .......................................................................................................................................................................
Alphameprodine .....................................................................................................................................................................
Benzethidine ...........................................................................................................................................................................
Betameprodine .......................................................................................................................................................................
Clonitazene .............................................................................................................................................................................
Dextromoramide .....................................................................................................................................................................
Isotonotazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) ...................................
Dimenoxadol ...........................................................................................................................................................................
Dimepheptanol .......................................................................................................................................................................
Dimethylthiambutene ..............................................................................................................................................................
Dioxaphetyl butyrate ...............................................................................................................................................................
Dipipanone .............................................................................................................................................................................
Etonitazene .............................................................................................................................................................................
Ketobemidone ........................................................................................................................................................................
Levomoramide ........................................................................................................................................................................
Noracymethadol .....................................................................................................................................................................
Normethadone ........................................................................................................................................................................
Piritramide ..............................................................................................................................................................................
Racemoramide .......................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine .............................................................................................................................
Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine ..........................................
Protonitazene (N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) ........................................
Para-Fluorofentanyl ................................................................................................................................................................
3-Methylfentanyl .....................................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ................................................
VerDate Sep<11>2014
21:46 Nov 22, 2023
Jkt 262001
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
E:\FR\FM\24NON1.SGM
24NON1
Schedule
7089
I
7173
7200
7201
7222
7225
7246
7249
7286
7297
7348
7385
7390
7391
7392
7395
7399
7400
7404
7432
7434
7435
7439
7455
7458
7470
7493
7508
7509
7518
7519
7521
7524
7532
7536
7537
7538
7543
7545
7546
7547
7694
9168
9312
9335
9547
9551
9560
9601
9604
9606
9608
9612
9613
9614
9617
9618
9619
9621
9622
9624
9628
9629
9633
9635
9642
9645
9661
9757
9759
9812
9813
9824
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
82403
Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices
Controlled substance
Drug code
Beta-hydroxyfentanyl ..............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ...............................................................................................................................................
3-Methylthiofentanyl ...............................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ....................................................................
Thiofentanyl ............................................................................................................................................................................
Beta-hydroxythiofentanyl ........................................................................................................................................................
Ocfentanil ...............................................................................................................................................................................
beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as b′-phenyl fentanyl; 3phenylpropanoyl fentanyl).
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .................................................................................
Crotonyl fentanyl ((E-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) ........................................................................
Cyclopropyl Fentanyl ..............................................................................................................................................................
ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl
fentanyl).
Nabilone .................................................................................................................................................................................
Alphaprodine ..........................................................................................................................................................................
Levomethorphan .....................................................................................................................................................................
Racemethorphan ....................................................................................................................................................................
Alfentanil .................................................................................................................................................................................
The company plans to import the
listed controlled substances for
distribution for analytical testing
purposes. No other activities for these
drug codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Drug Enforcement Administration
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
[Docket No. DEA–1297]
SUPPLEMENTARY INFORMATION:
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-25989 Filed 11-22-23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research Biochemicals, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Sigma Aldrich Research
Biochemicals, Inc. has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 23, 2024. Such
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
persons may also file a written request
for a hearing on the application on or
before January 23, 2024.
VerDate Sep<11>2014
21:46 Nov 22, 2023
Jkt 262001
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on October 27, 2023,
Sigma Aldrich Research Biochemicals,
Inc., 400–600 Summit Drive, Burlington,
Massachusetts 01803, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Lisdexamfetamine .........
Drug
code
1205
Schedule
I
The company plans to manufacture
the listed controlled substances as
reference standards. No other activities
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Schedule
9830
9831
9833
9834
9835
9836
9838
9842
I
I
I
I
I
I
I
I
9843
9844
9845
9846
I
I
I
I
7379
9010
9210
9732
9737
II
II
II
II
II
for these drug codes are authorized for
this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–25992 Filed 11–22–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1121–0330]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Law
Enforcement Congressional Badge of
Bravery
Office of Justice Programs,
Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Office of Justice
Programs, Bureau of Justice Assistance
(BJA), Department of Justice (DOJ), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
was previously published in the Federal
Register on September 15, allowing a
60-day comment period.
DATES: Comments are encouraged and
will be accepted for 30 days until
December 26, 2023.
FOR FURTHER INFORMATION CONTACT: If
you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact: Gregory Joy at 202–514–1369,
Policy Advisor, Bureau of Justice
Assistance, 810 7th Street NW,
SUMMARY:
E:\FR\FM\24NON1.SGM
24NON1
]]>Agencies
[Federal Register Volume 88, Number 225 (Friday, November 24, 2023)]
[Notices]
[Pages 82401-82403]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25989]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1294]
Importer of Controlled Substances Application: VHG Labs DBA LGC
Standards
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: VHG Labs DBA LGC Standards has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
December 26, 2023. Such persons may also file a written request for a
hearing on the application on or before December 26, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on November 6, 2023, VHG Labs DBA LGC Standards, 3
Perimeter Road, Manchester, New Hampshire 03103-3341, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Amineptine (7-[(10,11-dihydro- 1219 I
5Hdibenzo[a,d]cyclohepten-5-
yl)amino]heptanoic acid).
Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2- 1227 I
yl)-1,2,3-oxadiazol-3-ium-5-
yl)carbamimidate).
3-Fluoro-N-methylcathinone (3-FMC).......... 1233 I
4-Fluoro-N-methylcathinone (4-FMC) 1238 I N. 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
4-Methyl-N-ethylcathinone (4-MEC)........... 1249 I
Methiopropamine (N-methyl-1-(thiophen-2- 1478 I
yl)propan-2-amine) 1478 I N.
N,N-Dimethylamphetamine..................... 1480 I
Fenethylline................................ 1503 I
4-Methylaminorex (cis isomer)............... 1590 I
4,4'-Dimethylaminorex (4,4'-DMAR; 4,5- 1595 I
dihydro-4-1595 I N methyl-5-(4-
methylphenyl)-2-oxazolamine; 4-methyl-5-(4-
methylphenyl)-4,5-dihydro-1,3-oxazol-2-
amine).
Mecloqualone................................ 2572 I
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1- 7010 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- 7012 I
2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)..... 7019 I
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4- 7021 I
fluorobenzyl)-1Hindazole-3-carboxamido)-3-
methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7023 I
yl)-1-pentyl-1H-indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone).
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan- 7025 I
2-yl)-1-(5-fluropentyl)-1H-indazole-3-
carboximide).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan- 7031 I
2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5- 7034 I
fluoropentyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)- 7041 I
1H-indole-3-carboxamido)-3,3-
dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohexylmethyl)-1H-indole-3-carboxamido)-
3,3-dimethylbutanoate).
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1- 7049 I
(5-fluoropentyl)-1H-indazole-3-carboxamide).
[[Page 82402]]
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 7089 I
4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78
(1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-
1H-indazole-3-carboxamide).
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)..... 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) 7201 I
indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- 7225 I
1H-indole-3-carboxylate).
N-ethylhexedrone 7246 I N................... 7246 I
Alpha-ethyltryptamine....................... 7249 I
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan- 7286 I
1-one (methoxetamine).
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)- 7297 I
3-hydroxycyclohexyl-phenol).
2C-T-7 (2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine.
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine).
3,4,5-Trimethoxyamphetamine................. 7390 I
4-Bromo-2,5-dimethoxyamphetamine............ 7391 I
4-Bromo-2,5-dimethoxyphenethylamine......... 7392 I
4-Methyl-2,5-dimethoxyamphetamine........... 7395 I
2,5-Dimethoxy-4-ethylamphetamine............ 7399 I
3,4-Methylenedioxyamphetamine............... 7400 I
3,4-Methylenedioxy-N-ethylamphetamine....... 7404 I
Alpha-methyltryptamine...................... 7432 I
Diethyltryptamine........................... 7434 I
Dimethyltryptamine.......................... 7435 I
5-Methoxy-N,N-diisopropyltryptamine......... 7439 I
N-Ethyl-1-phenylcyclohexylamine............. 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine........... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine....... 7470 I
N-Benzylpiperazine.......................... 7493 I
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine).
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine).
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine).
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N- 7536 I
(2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)- 7537 I
N-(2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N- 7538 I
(2-methoxybenzyl) ethanamine).
N-Ethypentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-pentan-1-
one).
alpha-pyrrolidinopentiophenone ([alpha]-PVP) 7545 I
alpha-pyrrolidinobutiophenone ([alpha]-PBP). 7546 I
Ethylone.................................... 7547 I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) 7694 I
indole).
Difenoxin................................... 9168 I
Nicomorphine................................ 9312 I
Drotebanol.................................. 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol.............................. 9601 I
Alphameprodine.............................. 9604 I
Benzethidine................................ 9606 I
Betameprodine............................... 9608 I
Clonitazene................................. 9612 I
Dextromoramide.............................. 9613 I
Isotonotazene (N,N-diethyl-2-(2-(4 9614 I
isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-
yl)ethan-1-amine).
Dimenoxadol................................. 9617 I
Dimepheptanol............................... 9618 I
Dimethylthiambutene......................... 9619 I
Dioxaphetyl butyrate........................ 9621 I
Dipipanone.................................. 9622 I
Etonitazene................................. 9624 I
Ketobemidone................................ 9628 I
Levomoramide................................ 9629 I
Noracymethadol.............................. 9633 I
Normethadone................................ 9635 I
Piritramide................................. 9642 I
Racemoramide................................ 9645 I
1-Methyl-4-phenyl-4-propionoxypiperidine.... 9661 I
Metonitazene (N,N-diethyl-2-(2-(4- 9757 I
methoxybenzyl)-5-nitro-1Hbenzimidazol-1-
yl)ethan-1-amine.
Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- 9759 I
propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-
amine).
Para-Fluorofentanyl......................... 9812 I
3-Methylfentanyl............................ 9813 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
[[Page 82403]]
Beta-hydroxyfentanyl........................ 9830 I
Beta-hydroxy-3-methylfentanyl............... 9831 I
3-Methylthiofentanyl........................ 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4- 9834 I
yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl................................ 9835 I
Beta-hydroxythiofentanyl.................... 9836 I
Ocfentanil.................................. 9838 I
beta'-Phenyl fentanyl (N-(1- 9842 I
phenethylpiperidin-4-yl)-N,3-
diphenylpropanamide; also known as [beta]'-
phenyl fentanyl; 3-phenylpropanoyl
fentanyl).
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Crotonyl fentanyl ((E-N-(1- 9844 I
phenethylpiperidin-4-yl)-N-phenylbut-2-
enamide).
Cyclopropyl Fentanyl........................ 9845 I
ortho-Fluorobutyryl fentanyl (N-(2- 9846 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)butyramide; also known as 2-
fluorobutyryl fentanyl).
Nabilone.................................... 7379 II
Alphaprodine................................ 9010 II
Levomethorphan.............................. 9210 II
Racemethorphan.............................. 9732 II
Alfentanil.................................. 9737 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
distribution for analytical testing purposes. No other activities for
these drug codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-25989 Filed 11-22-23; 8:45 am]
BILLING CODE P
